Compounds > beta-lactams
Page last updated: 2024-09-04

beta-lactams and zithromax

beta-lactams has been researched along with zithromax in 26 studies

Compound Research Comparison

Studies
(beta-lactams)		Trials
(beta-lactams)		Recent Studies (post-2010)
(beta-lactams)		Studies
(zithromax)		Trials
(zithromax)		Recent Studies (post-2010) (zithromax)
7,5791793,3956,9641,2633,790

Protein Interaction Comparison

ProteinTaxonomybeta-lactams (IC50)zithromax (IC50)
30S ribosomal protein S6Escherichia coli K-120.3
30S ribosomal protein S7Escherichia coli K-120.3
50S ribosomal protein L15Escherichia coli K-120.3
50S ribosomal protein L10Escherichia coli K-120.3
50S ribosomal protein L11Escherichia coli K-120.3
50S ribosomal protein L7/L12Escherichia coli K-120.3
50S ribosomal protein L19Escherichia coli K-120.3
50S ribosomal protein L1Escherichia coli K-120.3
50S ribosomal protein L20Escherichia coli K-120.3
50S ribosomal protein L27Escherichia coli K-120.3
50S ribosomal protein L28Escherichia coli K-120.3
50S ribosomal protein L29Escherichia coli K-120.3
50S ribosomal protein L31Escherichia coli K-120.3
50S ribosomal protein L31 type BEscherichia coli K-120.3
50S ribosomal protein L32Escherichia coli K-120.3
50S ribosomal protein L33Escherichia coli K-120.3
50S ribosomal protein L34Escherichia coli K-120.3
50S ribosomal protein L35Escherichia coli K-120.3
50S ribosomal protein L36Escherichia coli K-120.3
30S ribosomal protein S10Escherichia coli K-120.3
30S ribosomal protein S11Escherichia coli K-120.3
30S ribosomal protein S12Escherichia coli K-120.3
30S ribosomal protein S13Escherichia coli K-120.3
30S ribosomal protein S16Escherichia coli K-120.3
30S ribosomal protein S18Escherichia coli K-120.3
30S ribosomal protein S19Escherichia coli K-120.3
30S ribosomal protein S20Escherichia coli K-120.3
30S ribosomal protein S2Escherichia coli K-120.3
30S ribosomal protein S3Escherichia coli K-120.3
30S ribosomal protein S4Escherichia coli K-120.3
30S ribosomal protein S5Escherichia coli K-120.3
30S ribosomal protein S8Escherichia coli K-120.3
30S ribosomal protein S9Escherichia coli K-120.3
50S ribosomal protein L13Escherichia coli K-120.3
50S ribosomal protein L14Escherichia coli K-120.3
50S ribosomal protein L16Escherichia coli K-120.3
50S ribosomal protein L23Escherichia coli K-120.3
30S ribosomal protein S15Escherichia coli K-120.3
50S ribosomal protein L17Escherichia coli K-120.3
50S ribosomal protein L21Escherichia coli K-120.3
50S ribosomal protein L30Escherichia coli K-120.3
50S ribosomal protein L6Escherichia coli K-120.3
30S ribosomal protein S14Escherichia coli K-120.3
30S ribosomal protein S17Escherichia coli K-120.3
30S ribosomal protein S1Escherichia coli K-120.3
50S ribosomal protein L18Escherichia coli K-120.3
50S ribosomal protein L2Escherichia coli K-120.3
50S ribosomal protein L3Escherichia coli K-120.3
50S ribosomal protein L24Escherichia coli K-120.3
50S ribosomal protein L4Escherichia coli K-120.3
50S ribosomal protein L22Escherichia coli K-120.3
50S ribosomal protein L5Escherichia coli K-120.3
30S ribosomal protein S21Escherichia coli K-120.3
50S ribosomal protein L25Escherichia coli K-120.3
50S ribosomal protein L36 2Escherichia coli K-120.3

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (7.69)18.2507
2000's12 (46.15)29.6817
2010's6 (23.08)24.3611
2020's6 (23.08)2.80

Authors

AuthorsStudies
Botta, GA; Debbia, EA; Marchese, A; Pesce, A; Saverino, D; Schito, GC1
Appelbaum, PC; Davies, TA; Jacobs, MR; Jueneman, SA; Pankuch, GA1
Fujikawa, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K1
Carryn, S; Mingeot-Leclercq, MP; Tulkens, PM; Van Bambeke, F1
Gonzalez, BE; Kaplan, SL; Martinez-Aguilar, G; Mason, EO1
Buxbaum, A; Gattringer, R; Georgopoulos, A; Graninger, W; Lagler, H; Sauermann, R; Stich, K1
Ibrahim, KH; Rennie, RP1
Toltzis, P1
Furuya, R; Iyoda, T; Kanayama, A; Kobayashi, I; Matsuzaki, K; Nakayama, H; Saika, T; Tanaka, M; Tatewaki, M1
Egawa, S; Endo, K; Hosobe, T; Kiyota, H; Kobayashi, I; Onodera, S; Suzuki, H; Takahashi, T1
Appelbaum, PC; Bogdanovich, T; Ednie, LM; Jones, RN; Kosowska-Shick, K; Smith, K1
Griffith, ME; Hospenthal, DR; Murray, CK1
Arlet, G; Join-Lambert, OF; Lecuit, M; Lefort, A; Lortholary, O1
Brown, SD; Critchley, IA; Janjic, N; Tillotson, GS; Traczewski, MM1
Azana, R; Boos, A; Conley, ME; Crawford, RI; Deans, GD; Hoang, L; Janz, L; Junker, A; Leo, SH; Morton, TL; Prendiville, J; Senger, C; Tilley, P; Turvey, SE1
Al-Nawas, B; Callaway, AS; Karbach, J; Wagner, W; Willershausen, B1
Boix, V; Merino, E; Portilla, J; Reus, S; Torrus, D1
Bottinelli, L; de Barsy, M; Greub, G1
Hatakeyama, S; Matsui, H; Morisawa, Y; Sasabuchi, Y; Sasahara, T; Suzuki, J; Yamada, T; Yasunaga, H1
Adami, ME; Alexiou, N; Giamarellos-Bourboulis, EJ; Gogos, C; Halvatzis, S; Kosmas, V; Koutoukas, P; Kyprianou, A; Kyprianou, M; Kyriakoudi, A; Kyriazopoulou, E; Lada, M; Makina, A; Niederman, MS; Pavlaki, M; Sinapidis, D; Stefos, A; Velissaris, D1
Ishida, T; Ito, A; Tachibana, H; Tokumasu, H; Washio, Y; Yamazaki, A1
Al-Salloum, J; Gillani, SW; Gulam, SM; Mahmood, RK1
Baalbaki, N; Giuliano, C; Hartner, CL; Johnson, L; Kale-Pradhan, P1
Abruzzi, J; Kopczynski, A; Montes, THM; Nedel, WL; Portela, LV; Rodolphi, MS; Strogulski, NR1
Goytia, M; Wadsworth, CB1
Greco Kinney, A; Hadique, S; Jain, P; Kovacic Scherrer, N; Sarkar, S; Wen, S1

Reviews

7 review(s) available for beta-lactams and zithromax

ArticleYear
Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children.
    The Pediatric infectious disease journal, 2004, Volume: 23, Issue:5

    Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactams; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Prospective Studies; Streptococcus pneumoniae; Treatment Failure

2004
Antimicrobial resistance in Haemophilus influenzae: how can we prevent the inevitable? Commentary on antimicrobial resistance in H. influenzae based on data from the TARGETed surveillance program.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Aug-15, Volume: 41 Suppl 4

    Topics: Azithromycin; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Macrolides; Microbial Sensitivity Tests

2005
Comparison of amoxicillin with alternative agents for the treatment of acute otitis media in children.
    Pharmacotherapy, 2005, Volume: 25, Issue:12 Pt 2

    Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Child; Clinical Trials as Topic; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Otitis Media

2005
Antimicrobial therapy of leptospirosis.
    Current opinion in infectious diseases, 2006, Volume: 19, Issue:6

    Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactams; Doxycycline; Fluoroquinolones; Humans; Leptospirosis

2006
Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia.
    Journal of clinical immunology, 2012, Volume: 32, Issue:6

    Topics: Adolescent; Adult; Agammaglobulinemia; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Chronic Disease; Ertapenem; Genetic Diseases, X-Linked; Helicobacter; Helicobacter Infections; Humans; Male; Ofloxacin; Phylogeny; Treatment Outcome

2012
Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review.
    The Journal of international medical research, 2021, Volume: 49, Issue:10

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clarithromycin; Community-Acquired Infections; Humans; Pneumonia, Bacterial

2021
Canary in the Coal Mine: How Resistance Surveillance in Commensals Could Help Curb the Spread of AMR in Pathogenic
    mBio, 2022, 10-26, Volume: 13, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; beta-Lactams; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria; Neisseria gonorrhoeae; Penicillin-Binding Proteins

2022

Other Studies

19 other study(ies) available for beta-lactams and zithromax

ArticleYear
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin.
    The new microbiologica, 1993, Volume: 16, Issue:4

    Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactams; Escherichia coli; Gram-Negative Bacteria; Klebsiella pneumoniae; Plasmids

1993
In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11

    Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactams; Drug Resistance, Microbial; Microbial Sensitivity Tests; Streptococcus pneumoniae

1998
Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Bronchopneumonia; Clarithromycin; Disease Models, Animal; Haemophilus Infections; Haemophilus influenzae; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Treatment Outcome

2001
Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:7

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; beta-Lactams; Ciprofloxacin; Fluoroquinolones; Gentamicins; Humans; Listeria monocytogenes; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Quinolines

2002
Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    International journal of antimicrobial agents, 2004, Volume: 24, Issue:3

    Topics: Anti-Bacterial Agents; Austria; Azithromycin; Bacterial Proteins; beta-Lactams; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Hungary; Josamycin; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Pharyngitis; Pharynx; Skin; Streptococcal Infections; Streptococcus pyogenes; Tetracycline Resistance; Tonsillitis; Vagina

2004
In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2006, Volume: 12, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Drug Synergism; Humans; Male; Neisseria gonorrhoeae

2006
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2006, Volume: 12, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Humans; Male; Neisseria gonorrhoeae

2006
Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominis.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

    Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; beta-Lactams; Cardiobacterium; Drug Resistance, Bacterial; Glycolipids; Ketolides; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Pyrrolidines; Quinolones; Streptococcus bovis; Viridans Streptococci

2006
Novel extended-spectrum beta-lactamase in Shigella sonnei.
    Emerging infectious diseases, 2007, Volume: 13, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Dysentery, Bacillary; Haiti; Humans; Male; Microbial Sensitivity Tests; Shigella sonnei; Travel

2007
National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Geography; Haemophilus influenzae; Health Surveys; Humans; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; United States

2007
Multiple resistance to betalactam antibiotics, azithromycin or moxifloxacin in implant associated bacteria.
    Clinical laboratory, 2013, Volume: 59, Issue:3-4

    Topics: Aza Compounds; Azithromycin; Bacteria; beta-Lactams; Dental Implants; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines

2013
Polyostotic osteitis in secondary syphilis in an HIV-infected patient.
    Sexually transmitted diseases, 2013, Volume: 40, Issue:8

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Doxycycline; Humans; Male; Osteitis; Radiography; Skull; Stevens-Johnson Syndrome; Syphilis; Treatment Outcome

2013
Antibiotic susceptibility of Estrella lausannensis, a potential emerging pathogen.
    Microbes and infection, 2014, Volume: 16, Issue:9

    Topics: Acanthamoeba castellanii; Animals; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Child, Preschool; Chlamydiales; Chlorocebus aethiops; Coculture Techniques; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, rRNA; Humans; Vero Cells

2014
Azithromycin plus β-lactam versus levofloxacin plus β-lactam for severe community-acquired pneumonia: A retrospective nationwide database analysis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:12

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Japan; Levofloxacin; Male; Middle Aged; Pneumonia, Bacterial; Severity of Illness Index; Treatment Outcome

2019
Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clarithromycin; Cohort Studies; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome

2020
Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis.
    Scientific reports, 2019, 12-05, Volume: 9, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Bacteremia; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Prospective Studies; Severity of Illness Index; Survival Analysis

2019
Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD.
    Journal of general internal medicine, 2022, Volume: 37, Issue:16

    Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Disease Progression; Humans; Pulmonary Disease, Chronic Obstructive; Retrospective Studies

2022
Antibiotic therapy does not alter mitochondrial bioenergetics in lymphocytes of patients with septic shock - A prospective cohort study.
    Mitochondrion, 2022, Volume: 66

    Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clavulanic Acid; Energy Metabolism; Humans; Lymphocytes; Meropenem; Mitochondria; Piperacillin, Tazobactam Drug Combination; Polymyxins; Prospective Studies; Shock, Septic; Vancomycin

2022
β-Lactams plus doxycycline versus azithromycin for treatment of severe community-acquired pneumonia in critically ill patients.
    The Journal of antimicrobial chemotherapy, 2023, Dec-01, Volume: 78, Issue:12

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Community-Acquired Infections; Critical Illness; Doxycycline; Drug Therapy, Combination; Humans; Pneumonia; Prospective Studies; Treatment Outcome

2023